A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults
NCT04552366
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
149
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
BIOLOGICAL:
Ad5-nCoV
Sponsor
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
Collaborators
[object Object]